Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenblum, W. I.
Right arrow Articles by Katusic, Z. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenblum, W. I.
Right arrow Articles by Katusic, Z. S.

(Stroke. 1997;28:186-189.)
© 1997 American Heart Association, Inc.


Articles

Tetrahydrobiopterin, a Cofactor for Nitric Oxide Synthase, Produces Endothelium-Dependent Dilation of Mouse Pial Arterioles

William I. Rosenblum, MD

the Medical College of Virginia/Virginia Commonwealth University, Department of Pathology, Division of Neuropathology, Richmond.

Background and Purpose Tetrahydrobiopterin (THBP) is an essential cofactor for nitric oxide synthase (NOS), which is responsible for the synthesis of the endothelium-derived relaxing factor (EDRF) responsible for mediating the vasorelaxation produced by acetylcholine (ACh). Previous publications suggest that EDRFACh is continuously synthesized and released from the endothelium of mouse pial arterioles. If so, then one may predict that addition of THBP will increase the local production of EDRFACh and produce an endothelium-dependent relaxation that can be blocked by application of a known inhibitor of NOS. This study tests the prediction.

Methods The pial vessels were observed at a continuously suffused craniotomy site by means of intravital television microscopy. The effects of topically applied THBP on diameter were monitored before and after endothelial damage and before and after local treatment with the NOS inhibitor N-guanidino-L-monomethyl arginine (LNMMA). The endothelial damage was produced by a helium-neon laser in the presence of Evans blue dye.

Results A dose-dependent relaxation was produced by 10-3 and 10-2 mol/L THBP. The response was virtually eliminated by endothelial injury. LNMMA 10-6 mol/L also greatly inhibited dilation.

Conclusions The data are consistent with all reports that THBP is a cofactor for constitutive endothelial NOS. The data are consonant with previous results suggesting that EDRFACh is continually synthesized and released. It appears that THBP increases this synthesis and consequently the local level of released EDRFACh. The continuous spontaneous synthesis/release of EDRFACh modulates basal tone and, according to other studies, helps maintain a platelet-free endothelial surface.

Editorial Comment

Zvonimir S. Katusic, MD, PhD, Guest Editor

Department of AnesthesiologyMayo Clinic, St Mary's HospitalRochester, Minn




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Liao, T. W. Hein, M. W. Vaughn, K.-T. Huang, and L. Kuo
Intravascular flow decreases erythrocyte consumption of nitric oxide
PNAS, July 20, 1999; 96(15): 8757 - 8761.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Heller, A. Unbehaun, B. Schellenberg, B. Mayer, G. Werner-Felmayer, and E. R. Werner
L-Ascorbic Acid Potentiates Endothelial Nitric Oxide Synthesis via a Chemical Stabilization of Tetrahydrobiopterin
J. Biol. Chem., January 5, 2001; 276(1): 40 - 47.
[Abstract] [Full Text] [PDF]